The Journal of infection
-
The Journal of infection · Feb 2010
Review Comparative StudyValidation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.
(1) To validate the Severe Community Acquired Pneumonia (SCAP) score in predicting 30-day mortality. (2) To validate its ability to identifying patients at low risk of death. (3) To compare it against the Pneumonia Severity Index (PSI), and the British Thoracic Society's CURB-65 rules. ⋯ The SCAP is valid to predict 30-day mortality among low-risk patients and identifies a larger proportion of patients as low-risk than the other studied rules.